A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

NCT07253285 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo cagrilintide
DRUG: Placebo semaglutide

Sponsor

Novo Nordisk A/S